Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Nita Patel's publication output changed over time?
ScholarIQpublication output · 2002–2021
Output grew0% over the shown period — from 1 works in 2002 to 1 in 2021.
1
1
1
2
1
1
3
1
20022007201120122013201720202021
What are the most-cited papers on Nita Patel?
ScholarIQmost cited works
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Cheryl Keech, Gary Albert, Iksung Cho, Andreana Robertson, Patricia Reed, Susan Neal, Joyce S. Plested, Mingzhu Zhu, Shane Cloney-Clark, Haixia Zhou, Gale Smith, Nita Patel, Matthew B. Frieman, Robert Haupt, James Logue, Marisa E. McGrath, Stuart Weston, Pedro A. Piedra, Chinar Desai, Kathleen Callahan, Maggie Lewis, Patricia Price-Abbott, Neil Formica, Vivek Shinde, Louis Fries, Jason D. Lickliter, Paul Griffin, Bethanie Wilkinson, Gregory M. Glenn
New England Journal of Medicine. 20201,249 CitationsOPEN ACCESS
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.
Bryce D. Smith, Rebecca L. Morgan, Geoff A. Beckett, Yngve Falck–Ytter, Deborah Holtzman, Chong‐Gee Teo, Amy Jewett, Brittney Baack, David B. Rein, Nita Patel, Miriam J. Alter, Anthony Yartel, John W. Ward
PubMed. 20121,000 Citations
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
Jing-Hui Tian, Nita Patel, Robert Haupt, Haixia Zhou, Stuart Weston, Holly Hammond, James Logue, Alyse D. Portnoff, James A. Norton, Mimi Guebre‐Xabier, Bin Zhou, Kelsey Jacobson, Sonia Maciejewski, Rafia Khatoon, Malgorzata Wisniewska, Will Moffitt, Stefanie Kluepfel-Stahl, Betty Ekechukwu, James F. Papin, Sarathi Boddapati, C. Jason Wong, Pedro A. Piedra, Matthew B. Frieman, Michael J. Massare, Louis Fries, Karin Lövgren Bengtsson, Linda Stertman, Larry Ellingsworth, Gregory M. Glenn, Gale Smith
Nature Communications. 2021529 CitationsOPEN ACCESS
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
Sandhya Bangaru, Gabriel Ozorowski, Hannah L. Turner, Aleksandar Antanasijevic, Deli Huang, Xiaoning Wang, Jonathan L. Torres, Jolene K. Diedrich, Jing-Hui Tian, Alyse D. Portnoff, Nita Patel, Michael J. Massare, John R. Yates, David Nemazee, James C. Paulson, Greg Glenn, Gale Smith, Andrew B. Ward
Science. 2020383 CitationsOPEN ACCESS
Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory Tract
Herren Wu, David S. Pfarr, Syd Johnson, Yambasu A. Brewah, Robert M. Woods, Nita Patel, Wendy I. White, James F. Young, Peter A. Kiener
S46058472. 2007382 Citations
Related on ScholarIQ
Novavax (United States)
Institution
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Paper
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.
Paper
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
Paper
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
Paper
Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory Tract
Paper